Candel Therapeutics
Candel Therapeutics is a Massachusetts-based biotechnology company that develops and commercializes oncolytic viral immunotherapies to treat cancer.
Business Model:
Revenue: $125k
Employees: 51-200
Industries / Tags:
Detailed Candel Therapeutics Information
Geographic Data
Address: 117 Kendrick Street
City: Needham
State: MA
Zip: 02494
Country: US
Financial Info
Stage:
post ipo debt
Raised Last:
$25M
Raised Total:$148M
Social
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
Candel Therapeutics is a Massachusetts-based biotechnology company that develops and commercializes oncolytic viral immunotherapies to treat cancer.
Contact Phone:
+16179165445
Contact Email:
Candel Therapeutics went public on 7/26/2021 on the NASDAQ
Listed Exchange:
NASDAQ
IPO Date:
7/26/2021
IPO Valuation:
$222M
Ticker Symbol:
CADL
IPO Price:
$8/share
Amount Raised:
$72M
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
